These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 9893671)

  • 1. Sequence-dependent antitumour efficacy of combination chemotherapy of nedaplatin, a novel platinum complex, with 5-fluorouracil in an in vivo murine tumour model.
    Uchida N; Takeda Y; Hojo K; Maekawa R; Sugita K; Yoshioka T
    Eur J Cancer; 1998 Oct; 34(11):1796-801. PubMed ID: 9893671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Augmented antitumor efficacy of combination chemotherapy of nedaplatin with 5-fluorouracil in in vivo murine and human tumor model].
    Uchida N; Takeda Y; Kasai H; Hojo K; Wada T; Nishida K; Maekawa R; Sugita K; Yoshioka T
    Gan To Kagaku Ryoho; 1998 Dec; 25(14):2267-74. PubMed ID: 9881084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced antitumor efficacy of nedaplatin with 5-fluorouracil against human squamous carcinoma xenografts.
    Takeda Y; Kasai H; Uchida N; Yoshida H; Maekawa R; Sugita K; Yoshioka T
    Anticancer Res; 1999; 19(5B):4059-64. PubMed ID: 10628354
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergy of the combination of nedaplatin with etoposide in murine and human lung carcinoma.
    Uchida N; Kasai H; Takeda Y; Maekawa R; Sugita K; Yoshioka T
    Anticancer Res; 1998; 18(1A):247-52. PubMed ID: 9568085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antitumor efficacy of nedaplatin, a novel platinum complex, with cyclophosphamide in murine and human tumor model.
    Uchida N; Takeda Y; Kasai H; Maekawa R; Sugita K; Yoshioka T
    Anticancer Res; 1998; 18(5A):3375-9. PubMed ID: 9858911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Augmented antitumor activity in combination chemotherapy of nedaplatin with etoposide].
    Uchida N; Kasai H; Takeda Y; Maekawa R; Sugita K; Yoshioka T
    Gan To Kagaku Ryoho; 1998 Jan; 25(1):79-87. PubMed ID: 9464333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequence-dependent antitumor efficacy of combination chemotherapy with nedaplatin, a newly developed platinum, and paclitaxel.
    Yamada H; Uchida N; Maekawa R; Yoshioka T
    Cancer Lett; 2001 Oct; 172(1):17-25. PubMed ID: 11595125
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Combination chemotherapy of paclitaxel followed by nedaplatin for human ovarian cancer].
    Uchida N; Yamada H; Maekawa R; Yoshioka T
    Gan To Kagaku Ryoho; 2002 Nov; 29(11):1943-9. PubMed ID: 12465394
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combination chemotherapy with nedaplatin and cyclophosphamide in human ovarian cancer model.
    Uchida N; Yoshida H; Yamada H; Wada T; Daikatsu K; Ikeuchi I; Maekawa R; Sugita K; Yoshioka T
    Jpn J Cancer Res; 1999 Aug; 90(8):887-94. PubMed ID: 10543262
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy combined with cis-diammine-glycolatoplatinum (nedaplatin) and 5-fluorouracil for Japanese stage II-IV esophageal cancer compared with cisplatin plus 5-fluorouracil regimen: a retrospective study.
    Yamashita H; Nakagawa K; Tago M; Igaki H; Nakamura N; Shiraishi K; Sasano N; Ohtomo K
    Dis Esophagus; 2006; 19(1):15-9. PubMed ID: 16364038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma.
    Kuwahara A; Yamamori M; Nishiguchi K; Okuno T; Chayahara N; Miki I; Tamura T; Inokuma T; Takemoto Y; Nakamura T; Kataoka K; Sakaeda T
    Int J Med Sci; 2009 Sep; 6(6):305-11. PubMed ID: 19834547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of combined nedaplatin and docetaxel therapy for human head and neck cancer in vivo.
    Yamada H; Maki H; Takeda Y; Orita S
    Anticancer Res; 2006; 26(2A):989-94. PubMed ID: 16619497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Chemoradiation using 5-fluorouracil (5-FU) and nedaplatin (NDP) for gynecological malignancy--the relation between hemotoxicity and sequence of 5-FU and NDP].
    Itoh Y; Ishihara S; Kumada S; Takai K; Iwata M; Nakamura T; Kawase S; Suzuki K; Mori Y; Hirasawa N; Satoh C; Fukushima H; Okuda T; Ota T; Yanagawa S; Ishigaki T
    Gan To Kagaku Ryoho; 2004 May; 31(5):797-9. PubMed ID: 15170996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Schedule-dependent antitumor activity and toxicity of combinations of 5-fluorouracil and cisplatin/carboplatin against L1210 leukemia-bearing mice.
    Fujimoto S
    Biol Pharm Bull; 2006 Nov; 29(11):2260-6. PubMed ID: 17077525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Phase II multicenter clinical trial of nedaplatin in the treatment of malignant tumors].
    Zhang P; Feng FY; Wu LY; Hu Y; Liu JW; Gao YJ; Guan XQ; Nan KJ; Suo AL; Wang XW; Zhang MH; Zhang WD; Li CW; Zhang Y; Zhao JB
    Zhonghua Zhong Liu Za Zhi; 2006 Mar; 28(3):230-4. PubMed ID: 16875614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of combination chemotherapy with 5-fluorouracil (5-FU) and nedaplatin (NDP): adverse effects and eecommended dose of NDP administered after 5-FU.
    Fuwa N; Kodaira T; Kamata M; Matsumoto A; Furutani K; Tachibana H; Ito Y
    Am J Clin Oncol; 2002 Dec; 25(6):565-9. PubMed ID: 12477999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preclinical in vivo antitumor efficacy of nedaplatin with gemcitabine against human lung cancer.
    Matsumoto M; Takeda Y; Maki H; Hojo K; Wada T; Nishitani Y; Maekawa R; Yoshioka T
    Jpn J Cancer Res; 2001 Jan; 92(1):51-8. PubMed ID: 11173544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of treatment sequence on efficacy of fluorouracil and cisplatin intratumoral drug delivery in vivo.
    Yu NY; Patawaran MB; Chen JY; Orenberg EK; Brown DM; Luck EE
    Cancer J Sci Am; 1995; 1(3):215-21. PubMed ID: 9166479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism(s) of antitumor action in protracted infusion of low dose 5-fluorouracil and cisplatin in gastric carcinoma.
    Kim R; Tanabe K; Inoue H; Toge T
    Int J Oncol; 2002 Mar; 20(3):549-55. PubMed ID: 11836567
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo comparative therapeutic study of optimal administration of 5-fluorouracil and cisplatin using a newly established HST-1 human squamous-carcinoma cell line.
    Kuroki M; Nakano S; Mitsugi K; Ichinose I; Anzai K; Nakamura M; Nagafuchi S; Niho Y
    Cancer Chemother Pharmacol; 1992; 29(4):273-6. PubMed ID: 1537072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.